Status:
COMPLETED
Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Innovation Fund Denmark
Conditions:
Hypoxemic Respiratory Failure
Hypoxia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to examine if automated oxygen delivery with O2matic allows for faster weaning from oxygen supply and better oxygen control than manually controlled oxygen therapy for patient...
Detailed Description
Closed-loop control of oxygen therapy is described in the literature used for preterm infants, trauma patients, medical emergency use, and for patients with Chronic Obstructive Pulmonary Disease (COPD...
Eligibility Criteria
Inclusion
- Admission with hypoxemic respiratory failure
- Age \>= 18 years
- Expected duration of admission \> 24 hours
- Need for oxygen supplementation to maintain SpO2 \>= 88 % (patients at risk of hypercapnia) or SpO2 \>= 94 % (other patients)
- Cognitively able to participate in the study
- Willing to participate and give informed consent
Exclusion
- Need or anticipated need for mechanical ventilation (intermittent Continuous Positive Airway Pressure (CPAP) is allowed)
- Patients with CO-poisoning or other condition with unreliable SpO2.
- Patients in need of oxygen supplementation at more than 10 liters/min
- Pregnancy
- Cognitive or language barriers for participation
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04079465
Start Date
October 1 2019
End Date
December 31 2023
Last Update
October 15 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Amager Hospital
Copenhagen, Denmark, 2300
2
Hvidovre Hospital
Hvidovre, Denmark, 2650